-55.9%
HUBS vs MRNA
+909.7%
-965.6%
-63.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.4% | -6.5% | +1.2% | -5.2% |
| 7D | -14.4% | +8.4% | -22.8% | -14.6% |
| 30D | -5.6% | +28.8% | -34.4% | -6.4% |
| 3M | -18.1% | +329.2% | -347.3% | -23.0% |
| 6M | -16.7% | +416.9% | -433.6% | -19.6% |
| YTD | -48.9% | +718.8% | -767.7% | -51.8% |
| 1Y | -55.9% | +924.9% | -980.8% | -58.5% |
| All | -55.9% | +909.7% | -965.6% | -58.5% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling